Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke

Stroke is one of the most leading causes of death and disability in the world. Complement system activation contributes to pathogenesis and neuronal damage following stroke. There are no defined biological serum markers to determine the severity of stroke in acute phases. The purpose of current stud...

Full description

Bibliographic Details
Main Authors: Ebrahim Kouchaki, Atousa Babamohammadi, Hassan Nikoueinejad, Mojtaba Sehat
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-05-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/919
_version_ 1818271177699753984
author Ebrahim Kouchaki
Atousa Babamohammadi
Hassan Nikoueinejad
Mojtaba Sehat
author_facet Ebrahim Kouchaki
Atousa Babamohammadi
Hassan Nikoueinejad
Mojtaba Sehat
author_sort Ebrahim Kouchaki
collection DOAJ
description Stroke is one of the most leading causes of death and disability in the world. Complement system activation contributes to pathogenesis and neuronal damage following stroke. There are no defined biological serum markers to determine the severity of stroke in acute phases. The purpose of current study was to determine the association of three complement activators, namely Pentraxin-3 (PTX3),M-ficolin, and Surfactant protein A (SPA) with the severity of ischemic stroke. This cross-sectional study was done on 82 patients diagnosed with ischemic stroke at 24-96 hours of initiation of the clinical symptoms during 2014-2015. The serum levels of PTX3, M-ficolin, and SPA were measured by enzyme-linked immunosorbent assay ( ELISA). The patients were divided in three stroke severity groups according to modified National Institute of Health Stroke Scale mNIHSS. The results showed that the more severity of the stroke was, the higher serum levels of three evaluated molecules (p<0.001) were. The correlation of serum level of PTX3, M-ficolin, and SPA with stroke severity was 0.732, 0.736, and 0.731, respectively. There is a strong association between serum levels of PTX3, M-ficolin, and SPA with the severity of ischemic stroke. Clinically, such association may be considered to evaluate the severity of the ischemic stroke.
first_indexed 2024-12-12T21:22:02Z
format Article
id doaj.art-5b10a00aea1b45cbbc846084489c6440
institution Directory Open Access Journal
issn 1735-1502
1735-5249
language English
last_indexed 2024-12-12T21:22:02Z
publishDate 2017-05-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Allergy, Asthma and Immunology
spelling doaj.art-5b10a00aea1b45cbbc846084489c64402022-12-22T00:11:33ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492017-05-01162919Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic StrokeEbrahim Kouchaki0Atousa Babamohammadi1Hassan Nikoueinejad2Mojtaba Sehat3Department of Neurology, Kashan University of Medical Sciences, Kashan, IranTrauma Research Center, Kashan University of Medical Sciences, Kashan, IranNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IranDepartment of Community Medicine, Kashan University of medical sciences, Kashan, IranStroke is one of the most leading causes of death and disability in the world. Complement system activation contributes to pathogenesis and neuronal damage following stroke. There are no defined biological serum markers to determine the severity of stroke in acute phases. The purpose of current study was to determine the association of three complement activators, namely Pentraxin-3 (PTX3),M-ficolin, and Surfactant protein A (SPA) with the severity of ischemic stroke. This cross-sectional study was done on 82 patients diagnosed with ischemic stroke at 24-96 hours of initiation of the clinical symptoms during 2014-2015. The serum levels of PTX3, M-ficolin, and SPA were measured by enzyme-linked immunosorbent assay ( ELISA). The patients were divided in three stroke severity groups according to modified National Institute of Health Stroke Scale mNIHSS. The results showed that the more severity of the stroke was, the higher serum levels of three evaluated molecules (p<0.001) were. The correlation of serum level of PTX3, M-ficolin, and SPA with stroke severity was 0.732, 0.736, and 0.731, respectively. There is a strong association between serum levels of PTX3, M-ficolin, and SPA with the severity of ischemic stroke. Clinically, such association may be considered to evaluate the severity of the ischemic stroke.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/919Ischemic strokePentraxin-3M-ficolinSurfactant protein A
spellingShingle Ebrahim Kouchaki
Atousa Babamohammadi
Hassan Nikoueinejad
Mojtaba Sehat
Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
Iranian Journal of Allergy, Asthma and Immunology
Ischemic stroke
Pentraxin-3
M-ficolin
Surfactant protein A
title Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
title_full Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
title_fullStr Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
title_full_unstemmed Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
title_short Association of Serum Levels of Pentraxin-3, M-ficolin, and Surfactant Protein A with the Severity of Ischemic Stroke
title_sort association of serum levels of pentraxin 3 m ficolin and surfactant protein a with the severity of ischemic stroke
topic Ischemic stroke
Pentraxin-3
M-ficolin
Surfactant protein A
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/919
work_keys_str_mv AT ebrahimkouchaki associationofserumlevelsofpentraxin3mficolinandsurfactantproteinawiththeseverityofischemicstroke
AT atousababamohammadi associationofserumlevelsofpentraxin3mficolinandsurfactantproteinawiththeseverityofischemicstroke
AT hassannikoueinejad associationofserumlevelsofpentraxin3mficolinandsurfactantproteinawiththeseverityofischemicstroke
AT mojtabasehat associationofserumlevelsofpentraxin3mficolinandsurfactantproteinawiththeseverityofischemicstroke